Health
Novel protection pathway makes cells resistant to viral infection – Drug Target Review
Researchers reveal that activating the MHC class II transactivator (CIITA) and CD74 genes protected cells against infection by Ebola and SARS-CoV-2.
Posted: 28 August 2020 | Hannah Balfour (Drug Target Review) | No comments yet
Researchers reveal that activating the MHC class II transactivator (CIITA) and CD74 genes protected cells against infection by Ebola and SARS-CoV-2.
Researchers have discovered a new cellular protection mechanism which they demonstrated can prevent viruses, including Ebola and coronaviruses like SARS-CoV-2, from infecting cells. According to the collaborators, the new understanding surrounding cellular mechanisms in…
-
General22 hours agoOf saints and sinners | The Spectator Australia
-
General22 hours agoSmall plane crashes into San Diego neighbourhood, setting homes and vehicles on fire
-
Noosa News13 hours agoTully Sugar Mill celebrates 100 years of cane harvesting amid floods and cyclones
-
General22 hours agoWhy the nation needs the Nationals to ditch Net Zero